State Street Corp Keros Therapeutics, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,203,383 shares of KROS stock, worth $12.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,203,383

Previous 1,113,590 8.06%

Holding current value

$12.4 Million

Previous $64.7 Million 70.54%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$15.64 - $70.0 $1.4 Million - $6.29 Million	89,793 Added 8.06%	1,203,383 $19 Million
Q3 2024 Nov 14, 2024	SELL	$41.68 - $58.07 $4.49 Million - $6.26 Million	-107,786 Reduced 8.82%	1,113,590 $64.7 Million
Q2 2024 Aug 14, 2024	SELL	$44.58 - $66.89 $15.2 Million - $22.8 Million	-341,519 Reduced 21.85%	1,221,376 $55.8 Million
Q1 2024 May 15, 2024	BUY	$41.26 - $70.48 $21 Million - $35.8 Million	508,528 Added 48.23%	1,562,895 $103 Million
Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $4.13 Million - $6.25 Million	152,367 Added 16.89%	1,054,367 $41.9 Million
Q3 2023 Nov 14, 2023	SELL	$31.57 - $43.02 $3.6 Million - $4.9 Million	-113,903 Reduced 11.21%	902,000 $28.8 Million
Q2 2023 Aug 14, 2023	BUY	$37.26 - $51.01 $2.67 Million - $3.66 Million	71,744 Added 7.6%	1,015,903 $40.8 Million
Q1 2023 May 15, 2023	SELL	$41.44 - $59.32 $993,689 - $1.42 Million	-23,979 Reduced 2.48%	944,159 $40.3 Million
Q4 2022 Feb 14, 2023	BUY	$39.45 - $51.77 $1.37 Million - $1.79 Million	34,626 Added 3.71%	968,138 $46.5 Million
Q3 2022 Nov 15, 2022	SELL	$27.8 - $40.12 $1.59 Million - $2.3 Million	-57,240 Reduced 5.78%	933,512 $35.1 Million
Q2 2022 Aug 15, 2022	BUY	$26.03 - $67.04 $7.99 Million - $20.6 Million	307,105 Added 44.92%	990,752 $27.4 Million
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $1.21 Million - $1.7 Million	28,655 Added 4.37%	683,647 $37.2 Million
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $823,098 - $1.4 Million	-22,276 Reduced 3.29%	654,992 $38.3 Million
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $50,051 - $74,744	-1,710 Reduced 0.25%	677,268 $26.8 Million
Q2 2021 Aug 16, 2021	SELL	$42.4 - $70.11 $1.9 Million - $3.14 Million	-44,845 Reduced 6.2%	678,978 $28.8 Million
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $16.1 Million - $22.4 Million	297,732 Added 69.88%	723,823 $44.6 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $11.8 Million - $27 Million	326,865 Added 329.41%	426,091 $30.1 Million
Q3 2020 Nov 10, 2020	BUY	$27.04 - $62.21 $384,373 - $884,315	14,215 Added 16.72%	99,226 $3.83 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $1.71 Million - $3.43 Million	85,011 New	85,011 $3.19 Million

Others Institutions Holding KROS

# of Institutions

172

Shares Held

29.9M

Call Options Held

341K

Put Options Held

102K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $266M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Keros Therapeutics, Inc. Transaction History